Projected Income Statement: Lhyfe

Forecast Balance Sheet: Lhyfe

balance-sheet-analysis-chart LHYFE
Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - -122 -60.6 17 77.8 135
Change - - -149.67% -71.94% 357.65% 73.52%
Announcement Date 4/22/22 3/22/23 3/28/24 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Lhyfe

Fiscal Period: December 2022 2023 2024 2025 2026
CAPEX 1 11.51 40.4 40.55 55.18 54.32
Change - 250.94% 0.37% 36.06% -1.54%
Free Cash Flow (FCF) 1 -26.57 -55.46 -75.3 -86.38 -60.75
Change - 108.74% 35.78% 14.71% -29.67%
Announcement Date 3/22/23 3/28/24 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Lhyfe

Fiscal Period: December 2021 2022 2023 2024 2025 2026

Profitability

      
EBITDA Margin (%) - -2,982.81% -2,133.64% -567.73% -69.83% 3.99%
EBIT Margin (%) - -3,185.09% -2,579.65% -677.3% -108.27% -4.68%
EBT Margin (%) - -4,527.72% -2,487.02% -807.52% -155.28% -19.95%
Net margin (%) - -4,529.65% -2,542.75% -752.29% -132.37% -13.02%
FCF margin (%) - -4,661.05% -4,211.01% -1,472.31% -293.18% -63.13%
FCF / Net Income (%) - 102.9% 165.61% 195.71% 221.49% 484.71%

Profitability

      
ROA - - - - - -
ROE - -40.53% - -49.15% -84.1% -36.7%

Financial Health

      
Leverage (Debt/EBITDA) - - - -0.58x -3.78x 35x
Debt / Free cash flow - - - -0.23x -0.9x -2.21x

Capital Intensity

      
CAPEX / Current Assets (%) - 2,019.82% 3,067.88% 792.91% 187.27% 56.45%
CAPEX / EBITDA (%) - -67.72% -143.79% -139.66% -268.18% 1,413.2%
CAPEX / FCF (%) - -43.33% -72.85% -53.85% -63.87% -89.42%

Items per share

      
Cash flow per share 1 - -0.4082 -0.5456 -0.685 -0.525 0.02
Change - - 33.66% 25.55% -23.36% -103.81%
Dividend per Share 1 - - - - - -
Change - - - - - -
Book Value Per Share 1 - 3.622 - 1.35 0.695 0.52
Change - - - - -48.52% -25.18%
EPS 1 -0.45 -0.7 -0.7 -0.7925 -0.8025 -0.2533
Change - 55.56% -0% 13.21% 1.26% -68.43%
Nbr of stocks (in thousands) - 47,879 47,868 47,891 47,891 47,891
Announcement Date 4/22/22 3/22/23 3/28/24 - - -
1EUR
Estimates
2024 *2025 *
P/E ratio -4.2x -4.15x
PBR 2.47x 4.79x
EV / Sales 34.5x 8.05x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

eps-dividend-chart LHYFE

Year-on-year evolution of the PER

evolution-chart LHYFE

Year-on-year evolution of the Yield

evolution-chart LHYFE
Trading Rating
Investor Rating
ESG MSCI
surperformance-ratings-light-chart LHYFEMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
3.330EUR
Average target price
5.220EUR
Spread / Average Target
+56.76%
Consensus

Annual profits - Rate of surprise